Skip to content

Clinical trials

Completed Genital Neoplasms, Female trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Genital Neoplasms, Female Status: Completed Clear all

34 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20023
20052
20061
20071
20081
20091
20101
20111
20122
20154
20165
20172
20182
20192
20201
20211
20222
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed34

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company4
AA Secord1
Advaxis, Inc.1
Amgen1
Belgian Gynaecological Oncology Group1
Boehringer Ingelheim1
Catalysis SL1
Cedars-Sinai Medical Center1
Copenhagen University Hospital, Rigshospitalet1
GamaMabs Pharma1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Genital Neoplasms, Female34
Ovarian Neoplasms14
Endometrial Neoplasms9
Uterine Neoplasms9
Fallopian Tube Neoplasms7
Urogenital Neoplasms7
Uterine Cervical Neoplasms7
Neoplasms6
Genital Diseases, Female5
Peritoneal Neoplasms5

Trials

Showing 26 to 34 of 34. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.